Trade ProPhase Labs, Inc. - PRPH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 2.64 |
| Open | 2.66 |
| 1-Year Change | -39.13% |
| Day's Range | 2.48 - 2.73 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 11, 2024 | 2.64 | -0.10 | -3.65% | 2.74 | 2.91 | 2.58 |
| Sep 10, 2024 | 2.73 | 0.08 | 3.02% | 2.65 | 2.83 | 2.63 |
| Sep 9, 2024 | 2.73 | 0.00 | 0.00% | 2.73 | 2.77 | 2.65 |
| Sep 6, 2024 | 2.78 | 0.35 | 14.40% | 2.43 | 2.96 | 2.40 |
| Sep 5, 2024 | 2.43 | -0.18 | -6.90% | 2.61 | 2.61 | 2.43 |
| Sep 4, 2024 | 2.48 | 0.00 | 0.00% | 2.48 | 2.60 | 2.46 |
| Sep 3, 2024 | 2.48 | -0.08 | -3.13% | 2.56 | 2.56 | 2.46 |
| Aug 30, 2024 | 2.51 | 0.00 | 0.00% | 2.51 | 2.69 | 2.47 |
| Aug 29, 2024 | 2.38 | -0.04 | -1.65% | 2.42 | 2.43 | 2.23 |
| Aug 28, 2024 | 2.38 | 0.16 | 7.21% | 2.22 | 2.47 | 2.16 |
| Aug 27, 2024 | 2.31 | -0.03 | -1.28% | 2.34 | 2.58 | 2.25 |
| Aug 26, 2024 | 2.40 | -0.17 | -6.61% | 2.57 | 2.60 | 2.40 |
| Aug 23, 2024 | 2.59 | -0.04 | -1.52% | 2.63 | 2.64 | 2.58 |
| Aug 22, 2024 | 2.73 | 0.10 | 3.80% | 2.63 | 2.73 | 2.63 |
| Aug 21, 2024 | 2.73 | -0.06 | -2.15% | 2.79 | 2.85 | 2.69 |
| Aug 20, 2024 | 2.74 | -0.09 | -3.18% | 2.83 | 2.83 | 2.73 |
| Aug 19, 2024 | 2.83 | 0.21 | 8.02% | 2.62 | 2.90 | 2.55 |
| Aug 16, 2024 | 2.38 | 0.20 | 9.17% | 2.18 | 2.55 | 2.16 |
| Aug 15, 2024 | 2.23 | -0.15 | -6.30% | 2.38 | 2.48 | 2.01 |
| Aug 14, 2024 | 2.38 | 0.00 | 0.00% | 2.38 | 2.53 | 2.33 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ProPhase Labs, Inc. Company profile
About ProPhase Labs Inc
ProPhase Labs, Inc. is a medical science and technology company. The Company operates through two segments: consumer products and diagnostic services. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. The diagnostic services segment provides COVID-19 diagnostic information services to a range of customers in the United States, including health plans, third party payers and government organizations. The Company is also engaged in development and distribution of a product line of OTC dietary supplements under the brand name of TK Supplements. The TK Supplements product line offers two men’s health products, including Legendz XL for sexual health and Triple Edge XL, an energy booster plus testosterone support.
Financial summary
BRIEF: For the nine months ended 30 September 2021, ProPhase Labs Inc revenues increased from $9.4M to $33.9M. Net loss before extraordinary items increased from $1.3M to $4.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects General and administration increase from $3.3M to $14.7M (expense).
Equity composition
Common Stock $.0005 Par, 12/10, 50M auth., 19,353,672 issd., less 4,646,053 shs. in Treas. @ $25.2M. Insiders & Stakeholder owns 43.95%. PO 2/91, 3M shares @ $.15 by Concorde Brokerage Corporation. 1/97, 2-for-1 stock split. FY '00 '01 fins. are RES due to disc. opr. Sum Qs reflect restated EPS. FY '02 Qs are restated for disc. opr.
| Industry: | Special Foods & Wellbeing Products |
711 Stewart Ave, Suite 200
Garden City
NEW YORK
NEW YORK 11530
US
News
ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com